Department of Ophthalmology, CHU Saint-Pierre and Brugmann, 1000 Brussels, Belgium.
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1050 Brussels, Belgium.
Int J Mol Sci. 2018 Apr 2;19(4):1056. doi: 10.3390/ijms19041056.
Diabetic retinopathy is a frequent eyesight threatening complication of type 1 and type 2 diabetes. Under physiological conditions, the inner and the outer blood-retinal barriers protect the retina by regulating ion, protein, and water flux into and out of the retina. During diabetic retinopathy, many factors, including inflammation, contribute to the rupture of the inner and/or the outer blood-retinal barrier. This rupture leads the development of macular edema, a foremost cause of sight loss among diabetic patients. Under these conditions, it has been speculated that retinal pigmented epithelial cells, that constitute the outer blood-retinal barrier, may be subjected to hyperosmolar stress resulting from different mechanisms. Herein, we review the possible origins and consequences of hyperosmolar stress on retinal pigmented epithelial cells during diabetic retinopathy, with a special focus on the intimate interplay between inflammation and hyperosmolar stress, as well as the current and forthcoming new pharmacotherapies for the treatment of such condition.
糖尿病性视网膜病变是 1 型和 2 型糖尿病常见的视力威胁性并发症。在生理条件下,内、外血视网膜屏障通过调节离子、蛋白质和水的进出来保护视网膜。在糖尿病性视网膜病变中,许多因素,包括炎症,导致内和/或外血视网膜屏障的破裂。这种破裂导致黄斑水肿的发展,这是糖尿病患者视力丧失的主要原因。在这些情况下,人们推测构成外血视网膜屏障的视网膜色素上皮细胞可能会受到不同机制引起的高渗应激。在此,我们综述了高渗应激在糖尿病性视网膜病变过程中对视网膜色素上皮细胞的可能起源和后果,特别关注炎症和高渗应激之间的密切相互作用,以及目前和即将出现的治疗这种情况的新的药物治疗方法。